Skip to main content

Advertisement

SpringerLink
Log in

The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Migraine is considered to be a polygenic multifactorial disease with various environmental and genetic etiologies. Tumor necrosis factor-alpha (TNF-α), a potent immunomodulator and pro-inflammatory cytokine, has been implicated in many pathological processes in brain. The hypothesis of this study was that migraine without aura (MWA) might be associated with TNF-α (-308) polymorphism, resulting in increased TNF-α production. Genotyping was performed on DNA extracted from peripheral leukocytes by PCR–SSP method in 221 patients with WMA and 183 healthy control subjects from Iranian population. The results showed that the frequency of −308 A variant allele was higher in MWA than in the control group (40.6% versus 22.3%, OR 3.73, 95% CI 2.4–5.82, p < 0.0001). TNF-α GA heterozygous genotype, high producer, was significantly more prevalent in patients with MWA than controls (74% versus 44.7%, p < 0.0001) whilst the low producer GG homozygous genotype was less frequent in patients compared with controls (22.4% versus 55.3%, p < 0.0001). The logistic regression analysis showed a significant association for TNF-α (−308A) female allele carriers with MWA at reproductive ages (OR 2.56; 95% CI, 1.57–4.16, p < 0.0001) when compared with their matched control subjects.

In conclusion, this study demonstrates an association of tumor necrosis factor-alpha (-308A) carriage with MWA, suggesting that carrying a high responder TNF-alpha-308A allele may be a genetic factor in increasing the susceptibility to develop MWA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ferrari MD (1998) Migraine. Lancet 351:1043–1051

    Article  PubMed  CAS  Google Scholar 

  2. Gallagher RM (2004) What do patients want from acute migraine treatment? Cephalalgia 24(Suppl)20:8–15

    Article  PubMed  Google Scholar 

  3. Diamond M (2002) The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine: data from American Migraine Study II. Neurology 58(suppl 6): S3–S9

    PubMed  Google Scholar 

  4. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF (2001) Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41:638–645

    Article  PubMed  CAS  Google Scholar 

  5. Menken M, Munsat TL, Toole JF (2000) The global burden of disease study: implications for neurology. Arch Neurol 57:418–20

    Article  PubMed  CAS  Google Scholar 

  6. Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964–82

    PubMed  CAS  Google Scholar 

  7. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH (1992) The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660–4

    PubMed  CAS  Google Scholar 

  8. Ferreira SH, Lorenzetti BB, Poole S (1993) Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol 110:1227–31

    PubMed  CAS  Google Scholar 

  9. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF (1995) Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 692:244–50

    Article  PubMed  CAS  Google Scholar 

  10. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ (1995) Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 7:1265–75

    Google Scholar 

  11. Sorkin LS, Xiao WH, Wagner R, Myers RR (1997) Tumor necrosis factor alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81:255–62

    Article  PubMed  CAS  Google Scholar 

  12. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 121(3):417–24

    Article  PubMed  CAS  Google Scholar 

  13. Covelli V, Munno I, Pellegrino NM, Altamura M, Decandia P, Marcuccio C, Di Venere A, Jirillo E (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurol (Napoli) 13(2):205–11

    CAS  Google Scholar 

  14. Covelli V, Munno I, Pellegrino NM, Di Venere A, Jirillo E, Buscaino GA (1990) Exaggerated spontaneous release of tumor necrosis factor-alpha/cachectin in patients with migraine without aura. Acta Neurol (Napoli) 12(4):257–63

    CAS  Google Scholar 

  15. Perini F, D’Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–31

    Article  PubMed  Google Scholar 

  16. Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T (1987) Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A 84(23):8535–9

    Article  PubMed  CAS  Google Scholar 

  17. Beutler B, Cerami A (1986) Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320(6063):584–8

    Article  PubMed  CAS  Google Scholar 

  18. Wilson AG, di Giovine FS, Blakemore AI, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1(5):353

    Article  PubMed  CAS  Google Scholar 

  19. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195–9

    Article  PubMed  CAS  Google Scholar 

  20. Hohjoh H, Nakayama T, Ohashi J, Miyagawa T, Tanaka H, Akaza T, Honda Y, Juji T, Tokunaga K (1999) Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 54:138–145

    Article  PubMed  CAS  Google Scholar 

  21. Goadsby PJ (2003) Migraine: diagnosis and management. Intern Med J 33:436–42

    Article  PubMed  CAS  Google Scholar 

  22. Miller SA, Dykes DD, Poleski HF (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  23. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS (1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43:456–63

    Article  PubMed  CAS  Google Scholar 

  24. Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV (1997) Cytokine gene polymorphism and heart transplant rejection. Transplantation 64: 776

    Article  PubMed  CAS  Google Scholar 

  25. Hahn AB, Kasten-Jolly JC, Constantino DM, Graffunder E, Singh TP, Shen GK, Conti DJ (2001) TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation 72:660–5

    Article  PubMed  CAS  Google Scholar 

  26. Trabace S, Brioli G, Lulli P, Morellini M, Giacovazzo M, Cicciarelli G, Martelletti P (2002) Tumor necrosis factor gene polymorphism in migraine. Headache 42:341–5

    Article  PubMed  Google Scholar 

  27. Rainero I, Grimaldi LM, Salani G, Valfre W, Rivoiro C, Savi L, Pinessi L (2004) Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine. Neurology 62(1):141–3

    PubMed  CAS  Google Scholar 

  28. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–7

    Article  PubMed  CAS  Google Scholar 

  29. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ (2001) Migraine and function of the immune system: a metaanalysis of clinical literature published between 1966 and 1999. Cephalalgia 21:549–557

    Article  PubMed  CAS  Google Scholar 

  30. Fargion S, Valenti L, Dongiovanni P, Fracanzani AL (2004) TNF alpha promoter polymorphisms. Methods Mol Med 98:47–58

    PubMed  CAS  Google Scholar 

  31. McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP (2001) Association between polymorphism in regulatory region of gene encoding tumor necrosis factor alpha and risk of Alzheimer’s disease and vascular dementia: a case-control study. Lancet 357:436–439

    Article  PubMed  CAS  Google Scholar 

  32. Nadel S, Newport MJ, Booy R, Levin M (1996) Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174:878–80

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Neurology, Sina Hospital, Hamadan University of Medical Sciences, Hamadan, Iran

    Shahir Mazaheri

  2. Dept. of Immunology, Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

    Mehrdad Hajilooi

  3. Dept. of Immunology and Microbiology, Sari Medical School, Mazandaran University of Medical Sciences, Sari, Iran

    Alireza Rafiei

Authors
  1. Shahir Mazaheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehrdad Hajilooi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alireza Rafiei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehrdad Hajilooi.

Additional information

M. Hajilooi and A. Rafiei contributed equally to this work.

Received in revised form: 10 April 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mazaheri, S., Hajilooi, M. & Rafiei, A. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura. J Neurol 253, 1589–1593 (2006). https://doi.org/10.1007/s00415-006-0270-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0270-4

Keywords

Search

Navigation